The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...

Accrual in this trial was suspended in March 2025 as a result of findings from the Checkmate 8HW trial, which showed that the ...

Jiangsu Hengrui Pharma has chalked up a first-in-class approval for retlirafusp alfa, a bifunctional drug that targets PD-L1 ...

SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

This case describes a woman in her mid-40s with recurrent colorectal cancer who developed severe dermatologic toxicity during ...

Durvalumab plus FLOT chemotherapy significantly improved event-free survival and overall survival in gastric and gastroesophageal junction cancers. The MATTERHORN trial's perioperative approach ...

Introduction: The combination of liposomal irinotecan with fluorouracil and leucovorin (Nal-IRI/FL) has shown efficacy in phase II trials for advanced biliary tract cancer (BTC) following ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. I was always so self-conscious about my body. I felt hotter when I was young and tan, 100 percent ...

Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it. The Food and Drug Administration (FDA) has updated ...